Saffron (Crocus sativus L.) has shown aphrodisiac effects in some animal and human studies.
To assess the efficacy and tolerability of saffron in fluoxetine-related sexual dysfunction.
This was a 4-week randomized double-blind placebo-controlled study. Thirty-six married male patients with major depressive disorder whose depressive symptoms had been stabilized on fluoxetine and had subjective complaints of sexual impairment entered the study. The patients were randomly assigned to saffron (15 mg twice per day) or placebo for 4 weeks. International Index of Erectile Function scale was used to assess sexual function at baseline and weeks 2 and 4.
Thirty patients finished the study. Baseline characteristics as well as baseline and final depressive symptoms scores were similar between the two groups. Effect of time × treatment interaction on the total score was significant [Greenhouse–Geisser-corrected, F (1.444, 40.434) = 6.154, P = 0.009]. By week 4, saffron resulted in significantly greater improvement in erectile function (P < 0.001) and intercourse satisfaction domains (P = 0.001), and total scores (P < 0.001) than the placebo group. Effect of saffron did not differ significantly from that of placebo in orgasmic function (P = 0.095), overall satisfaction (P = 0.334), and sexual desire (P = 0.517) domains scores. Nine patients (60%) in the saffron group and one patient (7%) in the placebo group achieved normal erectile function (score > 25 on erectile function domain) at the end of the study (P value of Fisher’s exact test = 0.005). Frequency of side effects were similar between the two groups.
Saffron is a tolerable and efficacious treatment for fluoxetine-related erectile dysfunction.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, Akhondzadeh S (2008) Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 115:515–519
Aizenberg D, Zemishlany Z, Weizman A (1995) Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 18:320–324
Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S (2007) Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 31:439–442
Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F (2004) Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med 4:12
Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, Amini H, Fallah-Pour H, Jamshidi AH, Khani M (2005) Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res 19:148–151
Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi S, Yousefi MH, Alimardani R, Jamshidi A, Zare F, Moradi A (2010a) Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther 35:581–588
Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A (2010b) A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology (Berl) 207:637–643
Andersson KE (2011) Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev 63:811–859
Atmaca M, Korkmaz S, Topuz M, Mermi O (2011) Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retrospective investigation. Psychiatry Investig 8:55–57
Aukst-Margetic B, Margetic B (2005) An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 29:754–756
Baldwin D, Hutchison J, Donaldson K, Shaw B, Smithers A (2008) Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670. J Psychopharmacol 22:55–63
Berger F, Hensel A, Nieber K (2011) Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices. Neuroscience 180:238–247
Boskabady MH, Ghasemzadeh Rahbardar M, Nemati H, Esmaeilzadeh M (2010) Inhibitory effect of Crocus sativus (saffron) on histamine (H1) receptors of guinea pig tracheal chains. Pharmazie 65:300–305
Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH (1999) Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 54:346–351
D’agostino N, Pizzichini D, Chiusano ML, Giuliano G (2007) An EST database from saffron stigmas. BMC Plant Biol 7:53
Damis M, Patel Y, Simpson GM (1999) Sildenafil in the treatment of SSRI-induced sexual dysfunction: a pilot study. Prim Care Companion J Clin Psychiatry 1:184–187
Debattista C, Solvason B, Poirier J, Kendrick E, Loraas E (2005) A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 66:844–848
Demyttenaere K, Jaspers L (2008) Review: bupropion and SSRI-induced side effects. J Psychopharmacol 22:792–804
Fava M, Rankin M (2002) Sexual functioning and SSRIs. J Clin Psychiatry 63(Suppl 5):13–16, discussion 23–15
Feder R (1991) Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry 52:163–164
Furukawa K, Nagao K, Ishii N, Uchiyama T (2003) Responses to serotonin (5HT) in isolated corpus cavernosum penis of rabbit. Int J Impot Res 15:267–271
Hensley PL, Nurnberg HG (2002) SSRI sexual dysfunction: a female perspective. J Sex Marital Ther 28(Suppl 1):143–153
Hollander E, Mccarley A (1992) Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 53:207–209
Hosseinzadeh H, Jahanian Z (2010) Effect of Crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother Res 24:726–730
Hosseinzadeh H, Sadeghnia HR (2005) Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 8:394–399
Hosseinzadeh H, Younesi HM (2002) Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2:7
Hosseinzadeh H, Ziaee T, Sadeghi A (2008) The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine 15:491–495
Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, Motamedshariaty VS, Mohajeri SA (2012) Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Res 26:381–386
Hull EM, Muschamp JW, Sato S (2004) Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 83:291–307
Keltner NL, Mcafee KM, Taylor CL (2002) Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care 38:111–116
Khori V, Alizadeh AM, Yazdi H, Rakhshan E, Mirabbasi A, Changizi S, Mazandarani M,Nayebpour M (2011) Frequency-dependent electrophysiological remodeling of the AV node by hydroalcohol extract of Crocus sativus L. (saffron) during experimental atrial fibrillation: the role of endogenous nitric oxide. Phytother Res doi:10.1002/ptr.3643
Landen M, Eriksson E, Agren H, Fahlen T (1999) Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 19:268–271
Michelson D, Kociban K, Tamura R, Morrison MF (2002) Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 36:147–152
Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De La Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E (1997) SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 23:176–194
Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S (2006) Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine 13:607–611
Nemati H, Boskabady MH, Ahmadzadef Vostakolaei H (2008) Stimulatory effect of Crocus sativus (saffron) on beta2-adrenoceptors of guinea pig tracheal chains. Phytomedicine 15:1038–1045
Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH (2005) Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol 97:281–284
Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S (2003) Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 289:56–64
Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, Cansever A, Uzun O, Ozgen F, Ozsahin A (2008) Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Hum Psychopharmacol 23:321–326
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830
Rosen RC, Allen KR, Ni X, Araujo AB (2011) Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 60:1010–1016
Shamsa A, Hosseinzadeh H, Molaei M, Shakeri MT, Rajabi O (2009) Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study. Phytomedicine 16:690–693
Shrivastava RK, Shrivastava S, Overweg N, Schmitt M (1995) Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 15:83–84
Taylor MJ, Rudkin L, Hawton K (2005) Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials. J Affect Disord 88:241–254
Waldinger MD, Olivier B (1998) Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 13(Suppl 6):S27–S33
Williams VS, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM (2006) Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 67:204–210
Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS (2010) Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey. J Psychopharmacol 24:489–496
This study was Dr. Hamid Sohrabi’s thesis for the degree of Doctor of Medicine. The study was supported by a grant from Tehran University of Medical Sciences to Professor Shahin Akhondzadeh (grant number: 8140). The trial was registered in Iranian Registry of Clinical Trials (registration number: IRCT138711121556N3, http://www.irct.ir/searchresult.php?id=1556&number=3).
Conflict of interest
The authors declare no conflict of interests.
About this article
Cite this article
Modabbernia, A., Sohrabi, H., Nasehi, AA. et al. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology 223, 381–388 (2012). https://doi.org/10.1007/s00213-012-2729-6
- Crocus sativus
- Erectile dysfunction
- Sexual dysfunction